Latest News Feed

Press Release Jun 11, 2025
Vitro Biopharma's AlloRx Stem Cell Therapy - Featured in New York Times Article on Health Secretary Kennedy's, Vision for Expanding Access to Regenerative Medicine

Company's Stem Cell Research Highlighted Amid National Policy Discussion on Alternative Therapies
Press Release Jun 10, 2025
Vitro Biopharma's AlloRx Stem Cell Therapy Featured in New York Times Article on Health Secretary Kennedy's Vision for Expanding Access to Regenerative Medicine

Company's Stem Cell Research Highlighted Amid National Policy Discussion on Alternative Therapies 
Press Release Jul 18, 2022
Vitro Biopharma Names Chris Furman Chief Executive Officer
Press Release Nov 17, 2021
Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells(R) to Treat Pitt Hopkins Syndrome, a rare form of Autism
Press Release Oct 10, 2021
Vitro Biopharma Inc. July 31st 2021; 3rd Quarter ended Financial Results of Operations and Shareholder Letter.
Press Release Aug 31, 2021
Vitro Biopharma Acquires Fitore Nutrition and Infinivive MD, Adding Revenues from Innovative Stem Cell Activation Products and Topical Cosmetic Stem Cell Serums.
Press Release Aug 19, 2021
Vitro Biopharma Signs Multi-Million Dollar Operating Service Contract with European Wellness Biomedical Group.
Press Release Jul 1, 2021
Vitro Biopharma Inc. April 30, 2021; 2nd Quarter ended Financial Results of Operations and Shareholder Letter
Press Release Apr 27, 2021
Vitro Biopharma Inc. January 31st 2021, 1st Quarter ended Financial Results of Operations and Shareholder Letter
Press Release Apr 6, 2021
Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells(R) to Treat COVID-19
Press Release Apr 3, 2021
Vitro Biopharma Retains Leading Health Care Executive as Acting Director of Regulatory Affairs & Director
Press Release Mar 9, 2021
Vitro Biopharma Year ended October 31st, 2020 Financial Results of Operations and Shareholder Letter
Press Release Oct 13, 2020
Vitro Biopharma Announces Changes in SEC Registration
Press Release Oct 1, 2020
Vitro Biopharma 3rd Quarter ended July 31st 2020 Financial Results of Operations
Press Release Jul 20, 2020
Vitro Biopharma Announces MaloneBailey L.L.P. as its new Auditors
Press Release Jul 14, 2020
Critically ill COVID-19 Patient Successfully Treated with Vitro Biopharma’s AlloRx Stem Cells(R)
Press Release Jul 13, 2020
Vitro Biopharma Announces Dr. Jack Zamora M.D. as it's Chief Medical Advisor
Press Release Jun 29, 2020
Vitro Bio-Pharma 2nd Quarter Ended April 30th 2020 Financial Results of Operations and Shareholder Letter
Press Release Jun 2, 2020
Vitro Biopharma Signs MOU with GIOSTAR for COVID-19 IND Using AlloRx Stem Cells
Press Release May 7, 2020
Vitro Diagnostic Inc. dba Vitro Biopharma Featured in New Research Report
Press Release Apr 21, 2020
Vitro Biopharma Submits IND Application to FDA for AlloRx Stem Cell(R) Therapy of COVID-19
Press Release Mar 26, 2020
Vitro Biopharma First Quarter ended January 31, 2020 Financial Results of Operations
Press Release Mar 18, 2020
Stem Cell Therapy for the Coronavirus COVID-19 Pandemic
Press Release Feb 27, 2020
Stem Cell Therapy for Coronavirus Infection
Press Release Jan 23, 2020
Vitro Biopharma 2019 CEO Shareholder Letter: Record Revenues Leading to Further Growth into 2020
Press Release Jan 22, 2020
Vitro Biopharma Announces up to a $1,000,000 Private Offering of Series A Convertible Preferred and Warrants
Press Release Nov 5, 2019
Leading Denver-Based Orthopedic Surgeon to Join Vitro Biopharma's Scientific Advisory Board
Press Release Sep 26, 2019
Vitro Biopharma 3rd Quarter ended July 31st 2019 Financial Results of Operations
Press Release Jun 18, 2019
Vitro Bio-Pharma 2nd Quarter Ended April 30th 2019 Financial Results of Operations
Press Release Apr 30, 2019
Vitro Biopharma Receives ISO 13485 Certification Supporting its Stem Cell Medical Tourism Initiative
Press Release Apr 2, 2019
Vitro Biopharma Obtains CLIA Certification Complimenting its Ongoing Stem Cell Clinical Trials
Press Release Mar 22, 2019
Vitro Biopharma 1st Quarter ended January 31st 2019 Financial Results of Operations
Press Release Mar 12, 2019
Vitro Biopharma Receives Approval for a Stem Cell Clinical Trial for Musculoskeletal Conditions by the Bahamas Ministry of Health
Press Release Jan 24, 2019
Vitro Biopharma 2018 CEO Shareholder Letter: Record Revenues from Stem Cell Treatments
Press Release Dec 11, 2018
Vitro Biopharma Receives ISO 9001 Certification
Press Release Oct 23, 2018
Vitro BioPharma Engages Senior Director of Sales and Marketing
Press Release Sep 24, 2018
Vitro Biopharma 3rd Quarter 2018 Financial Results of Operations and Shareholder Letter
Press Release Jun 26, 2018
Vitro Bio-Pharma 2nd Quarter Ended April 30th 2018 Financial Results of Operations
Press Release May 3, 2018
Vitro Bio-Pharma Debt Re-Capitalization and Executive Team Formation
Press Release Mar 23, 2018
Vitro Bio-Pharma 1st Quarter 2018 Financial Results of Operations
Press Release Dec 20, 2017
2017 CEO Shareholder Letter: Translation from R&D to Stem Cell Therapies Accelerates Revenue and Prospects for Future Growth
Press Release Nov 21, 2017
Vitro Biopharma Files Patent for Its Novel Stem Cell Line with Broad Application to Stem Cell Therapies
Press Release Aug 8, 2017
Vitro Biopharma Reports Positive Clinical Trial Results of Stem Cell Activation Therapy for Autism
Press Release Mar 29, 2017
Vitro Biopharma Receives Funding to Expand its Stem Cell Therapies
Press Release Nov 7, 2016
Vitro Biopharma Files New Patents for Stem Cell Therapy of Neurological Conditions
Press Release May 3, 2016
Vitro Biopharma Launches New Products to Advance Breast Cancer Treatment
Press Release Mar 1, 2016
Vitro Biopharma Announces Early 2016 Results: Increased Revenue and Expansion Activities to Fuel Growth
Press Release Dec 29, 2015
Vitro Biopharma Advances Stem Cell Activation Therapy for Concussion
Press Release Nov 4, 2015
CEO Letter to Shareholders: 2015 Results Expand Therapy Options for Concussion